Pustular skin lesions in patients treated with infliximab: report of two cases

被引：23

作者：

Starmans-Kool, MJF ^{[1
]}

Peeters, HRM ^{[1
]}

Houben, HHML ^{[1
]}

机构：

[1] Atrium Med Ctr, Dept Rheumatol, NL-6401 CX Heerlen, Netherlands

来源：

RHEUMATOLOGY INTERNATIONAL | 2005年 / 25卷 / 07期

关键词：

adverse events; infliximab; pustular psoriasis; TNF-alpha blockers;

D O I：

10.1007/s00296-004-0567-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Two cases are presented in which repeated use of the TNF-alpha blocker infliximab may have led to development of pustular skin lesions. These findings might result in an improved understanding regarding the safety of infliximab with long-term usage.

引用

页码：550 / 552

页数：3

共 17 条

[1]

[Anonymous], COCHRANE DATABASE SY

[2] Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors [J].

Berg, L ;

Lampa, J ;

Rogberg, S ;

van Vollenhoven, R ;

Klareskog, L .

ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (02) :133-139

[3] Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].

Chaudhari, U ;

Romano, P ;

Mulcahy, LD ;

Dooley, LT ;

Baker, DG ;

Gottlieb, AB .

LANCET, 2001, 357 (9271) :1842-1847

[4] Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands - A report of 7 cases and review of the literature [J].

DiCaudo, DJ ;

Connolly, SM .

ARCHIVES OF DERMATOLOGY, 2002, 138 (03) :361-365

[5] Review article: safety of infliximab in clinical trials [J].

Hanauer, SB .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 :16-22

[6] Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor α inhibitors [J].

Kaipiainen-Seppänen, O ;

Leino, M .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (01) :88-89

[7] Infliximab - An updated review of its use in Crohn's disease and rheumatoid arthritis [J].

Keating, GM ;

Perry, CM .

BIODRUGS, 2002, 16 (02) :111-148

[8] Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept [J].

Lee, JH ;

Slifman, NR ;

Gershon, SK ;

Edwards, ET ;

Schwieterman, WD ;

Siegel, JN ;

Wise, RP ;

Brown, SL ;

Udall, JN ;

Braun, MM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2565-2570

[9] Perspectives for TNF-α-targeting therapies [J].

Lorenz, Hanns-Martin ;

Kalden, Joachim R. .

ARTHRITIS RESEARCH & THERAPY, 2002, 4 (Suppl 3) :S17-S24

[10]

Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO

← 1 2 →